非抗生素干预预防女性复发性尿路感染:随机对照试验系统综述概览
该概览汇总27篇随机对照试验的系统综述,评估益生菌、D-甘露糖、阴道雌激素、蔓越莓、马尿酸乌洛托品、草药、增加饮水、全身雌激素、针灸和疫苗等非抗生素干预预防女性复发性尿路感染(rUTI)的效果。蔓越莓和马尿酸乌洛托品获系统综述支持,绝经后女性阴道雌激素亦获支持,但剂量、疗程和依从性仍存疑问;益生菌、D-甘露糖、草药、针灸和疫苗仍需更强证据。
要点
- 蔓越莓和马尿酸乌洛托品预防rUTI有系统综述支持,但最佳制剂和疗程未定。
- 绝经后女性阴道雌激素获支持,依从性促进策略尚不明确。
- 益生菌、D-甘露糖、草药、针灸和疫苗证据不足,需更强研究。
核心结论
- 蔓越莓、马尿酸乌洛托品及绝经后女性阴道雌激素获系统综述支持用于预防rUTI,但剂量、疗程和依从性问题未解决,其他干预需更强证据。
研究设计与样本
- 系统综述概览,检索Medline、Embase、CINAHL、Google Scholar和Cochrane 2014年1月至2025年5月,纳入27篇随机对照试验的系统综述,对象为≥16岁复发性尿路感染女性。
主要发现
- 27篇系统综述分别评估益生菌(n=9)、D-甘露糖(n=7)、阴道雌激素(n=7)、蔓越莓(n=6)、马尿酸乌洛托品(n=3)、草药(n=3)、增加饮水(n=2)、全身雌激素(n=4)、针灸(n=2)和疫苗(n=2),其中8篇考察联合策略。
- 蔓越莓和马尿酸乌洛托品获系统综述支持,绝经后女性阴道雌激素亦获支持,但剂量、疗程和依从性存疑。
- 益生菌、D-甘露糖、草药、针灸和疫苗的系统综述认为需更强证据;增加饮水对低摄入女性有益但最佳摄入量待研究。
- 许多干预的依从性和可接受性信息较少。
关键数值与推荐
- 复发性尿路感染定义为过去6个月内≥2次或过去12个月内≥3次尿路感染。
- 纳入标准为≥16岁复发性尿路感染女性的社区非抗生素干预随机对照试验系统综述,排除重症监护、留置导尿管及口服抗生素方案比较研究。
临床怎么用
- 全科医生可基于系统综述证据考虑蔓越莓、马尿酸乌洛托品预防女性rUTI,绝经后女性可考虑阴道雌激素;使用中需关注剂量、疗程和依从性,其他干预应告知证据不足。
局限性
- 许多干预的依从性和可接受性信息较少;蔓越莓最佳制剂、马尿酸乌洛托品疗程及阴道雌激素依从性促进策略尚不明确;益生菌、D-甘露糖、草药、针灸和疫苗证据基础需加强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent urinary tract infections (rUTIs), that is, ≥2 urinary tract infections (UTIs) in the past 6 months or ≥3 in the past 12 months, are common, have a substantial impact on quality of life, and cause major antibiotic use. AIM: To identify non-antibiotic interventions for prevention of rUTIs that have been assessed in systematic reviews, exploring their effectiveness, acceptability, and adherence. DESIGN AND SETTING: An overview of systematic reviews of randomised controlled trials (RCTs) on non-pharmaceutical and pharmaceutical (non-antibiotic) interventions for preventing rUTIs in women. METHOD: Medline, Embase, CINAHL, Google Scholar, and Cochrane from January 2014 to May 2025 were searched for systematic reviews of RCTs assessing the effectiveness of community-based non-antibiotic interventions for preventing UTI in women aged ≥16 years with rUTIs. Studies in intensive care units, relating to people with indwelling catheters, or comparing different oral antibiotic regimens were excluded. There were no limitations regarding outcome measures or language. RESULTS: In total, 27 systematic reviews met inclusion criteria evaluating probiotics (n = 9), D-mannose (n = 7), vaginal oestrogen (n = 7), cranberry (n = 6), methenamine hippurate (n = 3), herbal medicine (n = 3), increased fluid intake (n = 2), systemic oestrogen (n = 4), acupuncture (n = 2), and vaccines (n = 2). Eight examined combination strategies. Cranberry and methenamine hippurate use are supported by systematic reviews, as is vaginal oestrogen among postmenopausal women, although questions remain around dose, duration, and treatment adherence. Reviews of probiotics, D-mannose, herbal medicine, acupuncture, and vaccines concluded that stronger evidence is needed. Increased fluid intake benefits women with low intake, but further research is needed on optimal intake. There was little information on treatment adherence or acceptability for many interventions. CONCLUSION: For effective interventions, questions remain about promoting adherence (vaginal oestrogen), or optimal preparation (cranberry), or duration (methenamine). For other interventions a stronger evidence base is needed.
引用
- Santer M, Miller S, Fraser S, et al. Non-antibiotic interventions to prevent recurrent urinary tract infections in women: overview of systematic reviews of randomised controlled trials. Br J Gen Pract. 2026. PMID: 42225392. doi:10.3399/BJGP.2026.0055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。